Latest filings (excl ownership)
20-F
2023 FY
Annual report (foreign)
28 Dec 23
6-K
Current report (foreign)
24 Oct 23
20-F
2022 FY
Annual report (foreign)
15 Dec 22
D
$3.34M in equity / options / securities to be acquired, sold $1.67M, 7 investors
21 Apr 22
UPLOAD
Letter from SEC
22 Feb 22
CORRESP
Correspondence with SEC
14 Feb 22
6-K
Notice of Change of Auditors
4 Feb 22
UPLOAD
Letter from SEC
26 Jan 22
20-F
2021 FY
Annual report (foreign)
15 Dec 21
D
$1.31M in equity / options / securities to be acquired, sold $523.8K, 18 investors
31 Aug 21
D
$1.06M in equity, sold $1.06M, 3 investors
1 Apr 21
D
$1.42M in equity, sold $1.42M, 28 investors
16 Mar 21
20-F
2020 FY
Annual report (foreign)
14 Dec 20
D
$501.79K in equity, sold $501.79K, 15 investors
2 Sep 20
D
$1.05M in equity, sold $1.05M, 30 investors
15 Jun 20
D
$826.09K in debt / options / securities to be acquired, sold $826.09K, 22 investors
15 Jun 20
6-K
Unaudited Condensed Interim Consolidated Financial Statements
1 Jun 20
6-K
Unaudited Condensed Interim Consolidated Financial Statements
5 Mar 20
6-K
Cordovacann Appoints Seasoned Executive As Senior Advisor to the Ceo
25 Feb 20
6-K
Unaudited Condensed Interim Consolidated Financial Statements
19 Dec 19
20-F
2019 FY
Annual report (foreign)
12 Dec 19
6-K
Cordovacann Announces Letter of Intent to Acquire
10 Oct 19
6-K
Cordovacann Provides Update on Its California Market Initiative
6 Sep 19
D
$857.08K in equity / debt / securities to be acquired, sold $535.68K, 14 investors
29 Aug 19
6-K
Cordovacann Announces Closing of Convertible Debenture Units
16 Aug 19
6-K
Current Report
16 Jul 19
6-K
Current Report
21 Jun 19
6-K
Cordovacann Provides Update on Closing of California-based
12 Jun 19
6-K
Cordovacann Provides Update on the Closing of Oregon-based Cannabis-related Assets and the Launch of Retail Dispensary Business
7 Jun 19
6-K
Unaudited Condensed Interim Consolidated Financial Statements
30 May 19
6-K
Cordovacann Announces Closing of Non-brokered Private Placement
13 Mar 19
6-K
Unaudited Condensed Interim Consolidated Financial Statements
27 Feb 19
6-K
Report of Foreign Private Issuer
29 Jan 19
20-F
2018 FY
Annual report (foreign)
13 Dec 18
6-K
Unaudited Condensed Interim Consolidated Financial Statements
29 Nov 18
6-K
Cordovacann Secures Reputable and Rapidly Expanding Cannabis Business In Washington State
13 Nov 18
6-K
Current report (foreign)
31 Oct 18
6-K
Notice of Change of Auditor
24 Oct 18
6-K
Cordovacann Signs Letter of Intent
21 Sep 18
6-K
Report of Foreign Private Issuer
12 Sep 18
Latest ownership filings
No filings